Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Eclitasertib by Denali Therapeutics for Psoriasis: Likelihood of Approval
Eclitasertib is under clinical development by Denali Therapeutics and currently in Phase I for Psoriasis. According to GlobalData, Phase I...
Eclitasertib by Denali Therapeutics for Ulcerative Colitis: Likelihood of Approval
Eclitasertib is under clinical development by Denali Therapeutics and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase...
Eclitasertib by Denali Therapeutics for Inflammation: Likelihood of Approval
Eclitasertib is under clinical development by Denali Therapeutics and currently in Phase I for Inflammation. According to GlobalData, Phase I...